'US holds the key for better prospects of Indian pharma'

Tanmaya Desai of SBI Healthcare Opportunities Fund talks about the state of the Indian pharma sector

Schemes under SBI Mutual Fund gets Renamed

SBI Mutual Fund has proposed to change the name of the following funds with effect from May 16, 2018

Dividend Declared in Equity Funds of SBI Mutual Fund

SBI Mutual Fund has announced dividend under the following schemes: Scheme Dividend (Rs/unit)

The American factor

Over the years, pharma stocks have seen a dream run before they started limping recently. In this interview with Vibhu Vats, Tanmaya Desai of SBI Pharma Fund tells us the inside story of the sector

Revision in exit load structure of SBI MF Schemes

SBI Mutual Fund has revised the exit load structure of SBI Arbitrage Opportunities Fund, SBI FMCG Fu

Side effects of regulation

Tanmaya Desai, Fund Manager, SBI Pharma Fund believes that the Indian pharma story remains promising despite being hit by regulatory concerns in the US and currency volatility in emerging markets